We are thrilled to announce that Lumanity has been named a Medical Marketing and Media (MM+M) Awards finalist in the Use of Data and Analytics or Data Platform category.
Returning for its 22nd year, the MM+M Awards are the medical marketing industry’s premier awards program, dedicated to honoring the best in creativity and effectiveness in healthcare marketing and communications. Being recognized as a finalist is an extraordinary honor and a testament to the hard work and dedication of our incredible team.
Our nomination for best use of data and analytics highlights our commitment to the creative use of data—including manual and algorithmic, processing, integrations, fusions, and sourcing—to collectively deliver a better campaign outcome. Using our proprietary omnichannel platform, Omnichannel Network Engagement Experience (ONEE™), our partner was able to leverage a powerful and flexible Customer Data Platform (CDP) to synthesize various inbound data, establishing a more comprehensive view of customers while automating more relevant and personalized outbound multichannel executions. In our submission, we focused on showing how data played several critical roles from audience development to more informed touchpoints across both personal and non-personal engagements.
Several internal and external teams collaborated to dismantle data silos and establish a unified vision including creative, development/technology, media, client strategic services, brand marketing, analytics, and sales operations. A special thank you to AVEO Oncology, an LG Chem company, for partnering with us on the campaign and providing invaluable feedback and guidance.
Congratulations to all the finalists! Winners will be announced October 9th at Cipriani Wall Street in New York City.
